中国药学杂志
    
           首页  |  期刊介绍  |  编 委 会  |  投稿指南  |  期刊订阅  |  广告服务  |  会议信息  |  联系我们  | 
�й�ҩѧ��־ 2010, Vol. 45 Issue (15) :1127-1133    DOI:
�� �� ����Ŀ¼ | ����Ŀ¼ | ������� | �߼����� << | >>
������ҩ��ڷ���͸�ü������½�չ
�����ڣ�����
����˫��ҩҵ�ɷ����޹�˾������ 100102

Download: PDF (1227KB)   HTML (0KB)   Export: BibTeX or EndNote (RIS)      Supporting Info
ժҪ Ŀ�� ����������ҩ��ڷ���͸�ü������½�չ������ �Խ�������Ϊ�������˽�ڷ���͸���Ƽ��ķ�չ���򣬸����似���ص㡢��ҩ���ơ���� ������ҩ��ڷ���͸�ü������½�չ����������ҩ���ܽ�ȡ����Գ�Ĥ��Ӧ�á���϶������͸�á�˫��Ƭ�Ͷ��Ƭ�Լ��¼������¸����5�����档�����ص�����˹����ɢ������������͸��Ƭ�����黯��͸��Ƭ����������͸��Ƭ��θ��������͸���Լ��������ͼ������¼��������� ���Ÿ��ֽ���ѧ�ư�������ѧ������ѧ�ȵĽ�һ����չ�͸����¸��ϡ��¼����Ľ�һ��Ӧ�ã�������ҩ��ڷ���͸�õĿ����ؽ������������ǵ����ӣ���Щ�����ʲ��ѵ�ҩ��Ҳ�л����ܹ����Զ��ο����������С�
Service
�ѱ����Ƽ�������
�����ҵ����
�������ù�����
Email Alert
RSS
�����������
�ؼ����� ��͸��   ������ҩ��   ����   ��ҩ����     
Abstract��
Keywords��   
�ո�����: 2012-01-01;
���ñ���:   
.������ҩ��ڷ���͸�ü������½�չ[J]  �й�ҩѧ��־, 2010,V45(15): 1127-1133
.[J]  Chinese Pharmaceutical Journal, 2010,V45(15): 1127-1133
��
[1] VERMA R K�� ARORA S�� GARG S. Osmotic pumps in drug delivery[J]. Crit Rev Ther Drug Carrier Syst �� 2004��21(6):477-520.[2] VERMA R K�� KRISHNA D M�� GARG S. Formulation aspects in the development of osmotically controlled oral drug delivery systems[J]. J Controlled Release �� 2002��79(1-3):7-27.[3] ZANNOU E A�� STRENG W H�� STELLA V J. Osmotic properties of sulfobutylether and hydroxypropyl cyclodextrins[J]. Pharm Res�� 2001��18(8):1226-1231.[4] OKIMOTO K�� TOKUNAGA Y�� IBUKI R�� et al. Applicability of (SBE)7M-beta-CD in controlled-porosity osmotic pump tablets (OPTs)[J]. Int J Pharm �� 2004��286(1-2):81-88.[5] SOTTHIVIRAT S�� HASLAM J L�� STELLA V J. Controlled porosity-osmotic pump pellets of a poorly water-soluble drug using sulfobutylether-beta-cyclodextrin�� (SBE)7M-beta-CD�� as a solubilizing and osmotic agent[J]. J Pharm Sci �� 2007��96(9):2364-2374.[6] GAN Y�� PAN W S�� WEI M�� et al. Cyclodextrin complex osmotic tablet for glipizide delivery[J]. Drug Dev Ind Pharm �� 2002��28(8):1015-1021.[7] WU H�� YANG X G�� ZHANG Z H�� et al. Studies on preparation of osmotic pump tablets of bezafibrate[J]. Chin Pharm J ���й�ҩѧ��־���� 2008��43(20):1574-1578.[8] LIU L X�� WANG X C. Solubility-modulated monolithic osmotic pump tablet for atenolol delivery[J]. Eur J Pharm Biopharm �� 2008��68(2):298-302.[9] WU T�� PAN W�� CHEN J�� et al. Formulation optimization technique based on artificial neural network in salbutamol sulfate osmotic pump tablets[J]. Drug Dev Ind Pharm�� 2000��26(2):211-215.[10] WANG C�� CHEN F�� HENG P W�� et al. A novel time-controlled release system based on drug-resin complexes and elementary osmotic pump[J]. Chem Pharm Bull (Tokyo) �� 2008��56(4):457-463.[11] WANG C�� CHEN F�� LI J Z�� et al. Novel osmotic pump tablet using core of drug-resin complexes for time-controlled delivery system[J]. Yakugaku Zasshi �� 2008��128(5):773-782.[12] THOMBRE A G�� CARDINAL J R�� DENOTO A R�� et al. Asymmetric membrane capsules for osmotic drug delivery. I. Development of a manufacturing process[J]. J Controlled Release �� 1999��57(1):55-64.[13] THOMBRE A G�� CARDINAL J R�� DENOTO A R�� et al. Asymmetric membrane capsules for osmotic drug delivery II. In vitro and in vivo drug release performance[J]. J Controlled Release�� 1999��57(1):65-73.[14] THOMBRE A G�� DENOTO A R�� GIBBES D C. Delivery of glipizide from asymmetric membrane capsules using encapsulated excipients[J]. J Controlled Release�� 1999��60(2-3):333-341.[15] PHILIP A K�� PATHAK K. Osmotic flow through asymmetric membrane: a means for controlled delivery of drugs with varying solubility[J]. AAPS Pharm Sci Tech�� 2006��7(3):56.[16] PHILIP A K�� PATHAK K. Wet process-induced phase-transited drug delivery system: a means for achieving osmotic�� controlled�� and level A IVIVC for poorly water-soluble drug[J]. Drug Dev Ind Pharm�� 2008��34(7):735-743.[17] PHILIP A�� PATHAK K. In situ-formed asymmetric membrane capsule for osmotic release of poorly water-soluble drug[J]. PDA J Pharm Sci Technol�� 2007��61(1):24-36.[18] CHOUDHURY P K�� CHAUHAN C S�� RANAWAT M S. Osmotic delivery of flurbiprofen through controlled porosity asymmetric membrane capsule[J]. Drug Dev Ind Pharm�� 2007��33(10):1135-1141.[19] AM ENDE M T�� MILLER L A. Mechanistic investigation of drug release from asymmetric membrane tablets: effect of media gradients (osmotic pressure and concentration)�� and potential coating failures on in vitro release[J]. Pharm Res�� 2007��24(2):288-297.[20] OKIMOTO K�� OHIKE A�� IBUKI R�� et al. Factors affecting membrane-controlled drug release for an osmotic pump tablet (OPT) utilizing (SBE)7M-beta-CD as both a solubilizer and osmotic agent[J]. J Controlled Release�� 1999��60(2-3):311-319.[21] KANAGALE P�� LOHRAY B B�� MISRA A�� et al. Formulation and optimization of porous osmotic pump-based controlled release system of oxybutynin[J]. AAPS Pharm Sci Tech�� 2007��8(3):E53.[22] SOTTHIVIRAT S�� HASLAM J L�� LEE P I�� et al. Release mechanisms of a sparingly water-soluble drug from controlled porosity-osmotic pump pellets using sulfobutylether-beta-cyclodextrin as both a solubilizing and osmotic agent[J]. J Pharm Sci�� 2009��98(6):1992-2000.[23] PAN W S�� GAN Y. Advances of the study on the two-chamber osmotic controlled release preparations[J]. J Shenyang Pharm Univ������ҩ�ƴ�ѧѧ������ 2000��17(2):147-151.[24] LIU L�� KHANG G�� RHEE J M�� et al. Monolithic osmotic tablet system for nifedipine delivery[J]. J Controlled Release�� 2000��67(2-3):309-322.[25] LIU L X�� XU Q�� KHANG G�� et al. Unitary-core osmotic pump tablet for controlled release of water-insoluble drug[J]. Acta Pharm Sin��ҩѧѧ������ 2003��38(12):966-967.[26] LU E X�� JIANG Z Q�� ZHANG Q Z�� et al. A water-insoluble drug monolithic osmotic tablet system utilizing gum arabic as an osmotic�� suspending and expanding agent[J]. J Controlled Release�� 2003��92(3):375-382.[27] MALATERRE V�� METZ H�� OGORKA J�� et al. Benchtop-magnetic resonance imaging (BT-MRI) characterization of push-pull osmotic controlled release systems[J]. J Controlled Release�� 2009��133(1):31-36.[28] MALATERRE V�� OGORKA J�� LOGGIA N�� et al. Approach to design push-pull osmotic pumps[J]. Int J Pharm�� 2009��376(1-2):56-62.[29] LIU L�� KU J�� KHANG G�� et al. Nifedipine controlled delivery by sandwiched osmotic tablet system[J]. J Controlled Release�� 2000��68(2):145-156.[30] ZHANG Z H�� LI W�� NIE S F�� et al. Overcome side identification in PPOP by making orifices on both layers[J]. Int J Pharm�� 2009��371(1-2):1-7.[31] THOMBRE A G�� APPEL L E�� CHIDLAW M B�� et al. Osmotic drug delivery using swellable-core technology[J]. J Controlled Release�� 2004��94(1):75-89.[32] WAKODE R�� BHANUSHALI R�� BAJAJ A. Development and evaluation of push-pull based osmotic delivery system for pramipexole[J]. PDA J Pharm Sci Technol�� 2008��62(1):22-31.[33] LI W�� ZHANG Z H�� DU G N�� et al. Preparation of gliclazide push-pull osmotic pump system[J]. J Chin New Drugs���й���ҩ��־���� 2008��17(3):233-236.[34] WANG X�� NIE S F�� LI W�� et al. Studies on bi-layer osmotic pump tablets of water-insoluble allopurinol with large dose: in vitro and in vivo[J]. Drug Dev Ind Pharm�� 2007��33(9):1024-1029.[35] LIU L�� XU X. Preparation of bilayer-core osmotic pump tablet by coating the indented core tablet[J]. Int J Pharm�� 2008��352(1-2):225-230.[36] LIU L�� CHE B. Preparation of monolithic osmotic pump system by coating the indented core tablet[J]. Eur J Pharm Biopharm�� 2006��64(2):180-184.[37] LIU L�� KHANG G�� RHEE J M�� et al. Sandwiched osmotic tablet core for nifedipine controlled delivery[J]. Biomed Mater Eng�� 1999��9(5-6):297-310.[38] LIU L X�� KHANG G�� RHEE J M�� et al. Sandwiched osmotic pump tablet for controlled release of water-insoluble drug[J]. Acta Pharm Sin��ҩѧѧ������ 2003��38(8):620-623.[39] PARK J S�� SHIN J H�� LEE D H�� et al. A squeeze-type osmotic tablet for controlled delivery of nifedipine[J]. J Biomater Sci Polym Ed�� 2008��19(1):31-45.[40] LIU X�� CHEN D�� ZHANG R. Evaluation of monolithic osmotic tablet system for nifedipine delivery in vitro and in vivo[J]. Drug Dev Ind Pharm�� 2003��29(7):813-819.[41] LIN Y K�� HO H O. Investigations on the drug releasing mechanism from an asymmetric membrane-coated capsule with an in situ formed delivery orifice[J]. J Controlled Release�� 2003��89(1):57-69.[42] LI X D�� PAN W S�� NIE S F�� et al. Studies on controlled release effervescent osmotic pump tablets from traditional Chinese medicine compound recipe[J]. J Controlled Release�� 2004��96(3):359-367.[43] LI Y�� HOU S�� BI Y�� et al. Novel two-step release system for the traditional Chinese medicine compound Danshen[J]. Yakugaku Zasshi�� 2007��127(9):1473-1484.[44] WEI L�� LI J�� GUO L�� et al. Investigations of a novel self-emulsifying osmotic pump tablet containing carvedilol[J]. Drug Dev Ind Pharm�� 2007��33(9):990-998.[45] SHOKRI J�� AHMADI P�� RASHIDI P�� et al. Swellable elementary osmotic pump (SEOP): an effective device for delivery of poorly water-soluble drugs[J]. Eur J Pharm Biopharm�� 2008��68(2):289-297.[46] NOKHODCHI A�� MOMIN M N�� SHOKRI J�� et al. Factors affecting the release of nifedipine from a swellable elementary osmotic pump[J]. Drug Deliv�� 2008��15(1):43-48.[47] ZHANG Z H�� TANG X�� PENG B�� et al. Optimization of a floating osmotic pump system of dipyridamole using central composite design-response surface methodology[J]. Acta Pharm Sin��ҩѧѧ������ 2009��44(2):203-207.[48] ZHANG Z�� PENG B�� YANG X�� et al. Design and evaluation of a novel floating osmotic pump system[J]. J Pharm Pharm Sci�� 2009��12(1):129-137.[49] GUAN J�� ZHOU L�� PAN Y�� et al. A novel gastro-retentive osmotic pump capsule using asymmetric membrane technology: in vitro and in vivo evaluation[J]. Pharm Res��2010��27(1):105-114.[50] GUAN J�� ZHOU L�� NIE S�� et al. A novel gastric-resident osmotic pump tablet: in vitro and in vivo evaluation[J]. Int J Pharm�� 2010��383(1-2):30-36.
[1] ��� ���� ��ӱ Ф� �μ���.�����о��DZ��׻���ά�ض���΢�黯��ҩϵͳθ������Ϊ��Ӱ��[J]. �й�ҩѧ��־, 2011,46(7): 527-531
[2] ��� ������ ��ѩ�� ˹½��.�ԣ�΢�黯�Ƽ��Ĺ��廯����[J]. �й�ҩѧ��־, 2011,46(4): 245-248
[3] ��ΰ ��־�� ���� ���� ����[ʯҩ����������ҩ����.�������ټ�ҵ�����͸���Ϳ���Ƭ���Ʊ����ͷſ���[J]. �й�ҩѧ��־, 2011,46(19): 1500-1505
[4] ���� ���� �߳翭.���ᴨܺ�΢����͸������Ĥ��ɢ����ѧ�о����䴦���Ż�[J]. �й�ҩѧ��־, 2011,46(17): 1334-1339
[5] ���� ��� ��ɺ.���ᰲ����ͪ΢������͸��Ƭ�Ĵ���ɸѡ��������ҩģ�����[J]. �й�ҩѧ��־, 2011,46(15): 1179-1183
[6] ������ ������ �ߴ��� .�ڷ��������Ƽ�΢����pH���ؼ����о���չ[J]. �й�ҩѧ��־, 2011,46(12): 913-916
[7] ������ . �������Ƽ�����Ͳ�Ʒ����������ڵ����⼰�淶���ƽ���[J]. �й�ҩѧ��־, 2009,44(15): 1192-1193
[8] �����;�;�ź��;���˽�.��ЧҺ��ɫ�׷��ⶨ��ŵ������͸���Ϳ���Ƭ�ĺ���[J]. �й�ҩѧ��־, 2009,44(10): 799-800
[9] ��Ԩ ;��Ӣ��;��֮�� ;������.�����ײ�����ҩ�ﻺ�����е�Ӧ��[J]. �й�ҩѧ��־, 2009,44(07): 481-484
[10] ������;����;���巼;������.������ǰ��������ҩ�����ðе���о���չ[J]. �й�ҩѧ��־, 2009,44(03): 161-165
[11] ��ѩӥ;����ü;���ƿ�;���һ;���;����;����.����������͸�ÿ���Ƭ��Ȯ���ڵĵ������Ͷ���������Ч���о�[J]. �й�ҩѧ��־, 2008,43(23): 1815-1818
[12] ��޿;���Ǹ�;��־��;��ΰ;������.�����������ҩ�ﱽ��������͸��Ƭ������[J]. �й�ҩѧ��־, 2008,43(20): 1574-1578
[13] �¾�;������;����Т.������ҩ�ﰢ���������о��͸��Ƭ���Ʊ�[J]. �й�ҩѧ��־, 2008,43(09): 680-682
[14] ������;������;ë����;������;֣��.һ�ֲ��ʱ����ҩϵͳ��ҩ�����о�[J]. �й�ҩѧ��־, 2007,42(18): 1393-1398
[15] ������ ;��־��;������;֣����.��κ����΢����͸��Ƭ������ҩ��ѧ���������ö�[J]. �й�ҩѧ��־, 2007,42(04): 295-297
Copyright 2010 by �й�ҩѧ��־